27% profit every 20 days?
This is what Nic Chahine averages with his option buys. Not selling covered calls or spreads… BUYING options. Most traders don’t even have a winning percentage of 27% buying options. He has an 83% win rate. Here’s how he does it.
The stock market pulled back like clockwork over the last few weeks as the S&P 500 fell six percent from an all-time high to the low on Wednesday.
Looking back at the last 15 months, the largest pullback the index suffered was six percent and each time the sell-off hit the four to six percent range it resulted in a market rally to a new high.
ENTER TO WIN $500 IN STOCK OR CRYPTO
Enter your email and you'll also get Benzinga's ultimate morning update AND a free $30 gift card and more!
Add in the CBOE Volatility Index (VIX) hitting a yearly closing high this week and it was a great setup for stocks to bounce. The jobs number on Friday morning was the one wild card that could have trumped all the technical indicators, but not even a poor number could hold back the equity rally.
See also: ETF Outlook For The Week Of February 10
At this point it appears buying into the current weakness is the best strategy for intermediate to long-term investors. There are a number of ETFs that are still trading off their highs and the lower prices are creating an opportunity for investors.
PowerShares Dynamic Pharmaceutical ETF (NYSE: PJP)
The ETF is a basket of 30 U.S. pharmaceutical stocks based on a number of factors that include price and earnings momentum, quality, management action and value. During the pullback the ETF fell by seven percent and held the 50-day moving average for all but two days. What differentiates PJP from its peers is that it includes both biotech and large pharmaceutical companies versus a concentration on one or the other.
The top three holdings are Merck (NYSE: MRK), Biogen Idec (NASDAQ: BIIB) and Gilead Sciences (NASDAQ: GILD). The expense ratio is a little higher than competitors at 0.63 percent, however it is worth it based on past performance.
First Trust ISE Cloud Computing ETF (NYSE: SKYY)
The niche technology ETF has a distinction that not many ETFs can brag about this week. The ETF did not close below its 50-day moving average during the pullback, a feat that is impressive considering the market-wide selling. Sitting less than one percent off its all-time high hardly represents a pullback, however the relative strength makes the ETF a buy candidate. The top holdings include Juniper Networks (NASDAQ: JNPR), F5 Networks (NASDAQ: FFIV) and Akamai Technologies (NASDAQ: AKAM).
SPDR S&P 500 ETF (NYSE: SPY)
If the goal is to capture the market, SPY is a great choice. The ETF tracks the movement of the S&P 500, which contains the largest 500 stocks in the U.S. If the pattern of pulling back six percent and rallying continues, SPY should see a sizable gain in the coming weeks. Because the ETF encompasses all sectors it will help investors take a more diversified approach versus the first two ETFs mentioned.
27% profit every 20 days?
This is what Nic Chahine averages with his option buys. Not selling covered calls or spreads… BUYING options. Most traders don’t even have a winning percentage of 27% buying options. He has an 83% win rate. Here’s how he does it.